More recent data demonstrated that a preoperative CRP increase is predictive for prognosis in myeloma bone disease post-surgery, and also, elevated values identify a high-risk subgroup in multiple myeloma individuals undergoing delayed autologous stem cell transplantation; however, generally, CRP has been reported as a predictive marker of cachexia in myeloma and lymphoma cases [785,786,787,788,789]. The gene discussed is CRP; the disease is plasma cell myeloma.